Contrast-Enhanced Digital Breast Tomosynthesis Compared With Contrast-Enhanced Mammography and Magnetic Resonance Imaging in the Assessment of Breast Lesions: A Pilot Study
- PMID: 39621875
- DOI: 10.1097/RLI.0000000000001138
Contrast-Enhanced Digital Breast Tomosynthesis Compared With Contrast-Enhanced Mammography and Magnetic Resonance Imaging in the Assessment of Breast Lesions: A Pilot Study
Abstract
Objectives: Contrast-enhanced mammography (CEM) is an accurate competitor for contrast-enhanced breast magnetic resonance imaging (CE-MRI), but the examination is limited by the lack of 3D information. Digital breast tomosynthesis (DBT) allows better lesion detection and characterization compared with mammography. The availability of quasi-3D contrast imaging could further improve the performance of CEM. The aim of our analysis was to compare the diagnostic performance of a contrast-enhanced digital breast tomosynthesis prototype (CE-DBTp) to CEM and to CE-MRI.
Materials and methods: This prospective study was approved by the ethics committee, and all patients gave written informed consent. Women who presented with suspicious findings on mammography, DBT, or ultrasound were invited to participate in the study. Participants underwent CEM and CE-DBTp of the breast with the suspicious findings as well as bilateral CE-MRI. Histology was used as the standard of reference. Four readers (R1 and R2 non-experienced; R3 and R4 experienced) evaluated the images, blinded to patients' history, previous imaging, and histology. The readers evaluated CEM, CE-DBTp, and CE-MRI in separate sessions and gave a BI-RADS score for each finding. Sensitivity, specificity, lesion conspicuity, and readers' confidence were calculated and compared.
Results: We included 84 patients (mean age, 56 years; range, 39-70) with 91 histologically verified breast lesions (27 benign, 64 malignant). The accuracy of the CE-DBTp was high, but significant differences were seen between experienced (both 86.8%) and non-experienced readers (76.9% and 78%, P = 0.021). No differences were found between CEM and CE-DBTp, whereas the accuracy of CE-MRI was higher ( P = 0.002). Sensitivity with CE-DBTp varied (89.1% to 100%) between experienced and non-experienced readers ( P = 0.074), and it was comparable to CEM but lower than CE-MRI ( P = 0.003). Specificity was variable between readers with all modalities. Lesion conspicuity was higher for the CE-DBTp and CE-MRI than for CEM, and confidence was significantly higher with the CE-DBTp than with CEM for one of the readers ( P < 0.001).
Conclusions: A high sensitivity and good accuracy were achieved with the CE-DBTp. Lesion conspicuity and readers' confidence were higher with the CE-DBTp compared with CEM. However, CE-MRI had the highest sensitivity and accuracy.
Keywords: breast; contrast media; magnetic resonance imaging; mammography; neoplasms; prospective studies.
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
Conflicts of interest and sources of funding: The study is supported by a grant from Siemens Healthineers.
Similar articles
-
Low-Dose, Contrast-Enhanced Mammography Compared to Contrast-Enhanced Breast MRI: A Feasibility Study.J Magn Reson Imaging. 2020 Aug;52(2):589-595. doi: 10.1002/jmri.27079. Epub 2020 Feb 14. J Magn Reson Imaging. 2020. PMID: 32061002 Free PMC article.
-
A head-to-head comparison of breast lesion's conspicuity at contrast-enhanced mammography and contrast-enhanced MRI.Eur Radiol. 2025 Jun;35(6):3070-3079. doi: 10.1007/s00330-024-11195-4. Epub 2024 Dec 3. Eur Radiol. 2025. PMID: 39625504 Free PMC article.
-
Multireader comparison of contrast-enhanced mammography versus the combination of digital mammography and digital breast tomosynthesis in the preoperative assessment of breast cancer.Radiol Med. 2021 Nov;126(11):1407-1414. doi: 10.1007/s11547-021-01400-5. Epub 2021 Jul 24. Radiol Med. 2021. PMID: 34302599
-
Contrast-enhanced Mammography versus Contrast-enhanced Breast MRI: A Systematic Review and Meta-Analysis.Radiology. 2022 Oct;305(1):94-103. doi: 10.1148/radiol.212530. Epub 2022 Jun 7. Radiology. 2022. PMID: 36154284
-
Evaluation of architectural distortion with contrast-enhanced mammography.Clin Radiol. 2024 Mar;79(3):163-169. doi: 10.1016/j.crad.2023.11.021. Epub 2023 Dec 10. Clin Radiol. 2024. PMID: 38114374 Review.
Cited by
-
Overcoming Barriers for Breast Cancer Detection in Women with High Breast Density [Letter].Patient Prefer Adherence. 2025 Feb 15;19:359-360. doi: 10.2147/PPA.S518898. eCollection 2025. Patient Prefer Adherence. 2025. PMID: 39974668 Free PMC article. No abstract available.
References
-
- Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov . 2022;12:31–46.
-
- van Nijnatten TJA, Morscheid S, Baltzer PAT, et al. Contrast-enhanced breast imaging: current status and future challenges. Eur J Radiol . 2024;171:111312.
-
- Berg WA, Bandos AI, Sava MG. Analytic hierarchy process analysis of patient preferences for contrast-enhanced mammography versus MRI as supplemental screening options for breast cancer. J Am Coll Radiol . 2023;20:758–768.
-
- Woolen SA, Troost JP, Khalatbari S, et al. Prospective multicenter assessment of patient preferences for properties of gadolinium-based contrast media and their potential socioeconomic impact in a screening breast MRI setting. Eur Radiol . 2021;31:9139–9149.
-
- Heindel W, Weigel S, Gerß J, et al. Digital breast tomosynthesis plus synthesised mammography versus digital screening mammography for the detection of invasive breast cancer (TOSYMA): a multicentre, open-label, randomised, controlled, superiority trial. Lancet Oncol . 2022;23:601–611.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical